Skip to main content
. 2018 Aug 24;54(4):57. doi: 10.3390/medicina54040057

Table 3.

Potentially inappropriate medications (PIMs) prescribing pattern among study participants.

Sr. Medicines ATC Code No Formal Education (N = 150) Primary (n = 63) Secondary (N = 129) Tertiary (N = 43) Total (n = 385) Trend
1 Aspirin N02BA01 56 (37.3) 28 (44.4) 30 (23.3) 11 (25.6) 125 (32.4)) High
2 Amlodipine C08CA01 18 (12.0) 9 (14.3) 4 (3.1) 1 (2.3) 32 (8.3) Medium
3 Alprazolam N05BA12 5 (3.3) 6 (9.5) 4 (3.1) 0 (0.0) 15 (3.8) Low
4 Atropine A03BA01 8 (5.3) 3 (4.8) 0 (0.0) 3 (7.0) 14 (3.6) Low
5 Aripiprazole N05AX12 1 (0.7) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.2) Low
6 Chlorpheniramine R06AB04 1 (0.7) 1 (1.6) 2 (1.6) 0 (0.0) 4 (1.0) Low
7 Clonazepam N03AE01 1 (0.7) 2 (3.2) 0 (0.0) 3 (7.0) 6 (1.5) Low
8 Chlorzoxazone M03BB03 2 (1.3) 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.5) Low
9 Caffeine N06BC01 1 (0.7) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.2) Low
10 Chlorpromazine N05AA01 0 (0.0) 2 (3.2) 0 (0.0) 0 (0.0) 2 (0.5) Low
11 Diclofenac Sodium M01AB05 9 (6.0) 4 (6.3) 9 (7.0) 0 (0.0) 22 (5.7) Medium
12 Dimenhydrinate R06AA52 4 (2.7) 2 (3.2) 2 (1.6) 4 (9.3) 12 (3.1) Low
13 Digoxin C01AA05 5 (3.3) 3 (4.8) 0 (0.0) 0 (0.0) 8 (2.0) Low
14 Diphenhydramine R06AA02 7 (5.3) 2 (3.2) 9 (7.0) 5 (11.6) 23 (5.9) Medium
15 Diltiazem HCL C08DB01 4 (2.7) 1 (1.6) 0 (0.0) 0 (0.0) 5 (1.2) Low
16 Dexamethasone R01AD03 3 (2.0) 5 (7.9) 0 (0.0) 3 (7.0) 11 (2.8) Low
17 Doxazosin C02CA04 0 (0.0) 1 (1.6) 0 (0.0) 0 (0.0) 1 (0.2) Low
18 Ephedrine R01AA03 2 (1.3) 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.5) Low
19 Esomeprazole A02BC05 16 (10.7) 3 (4.8) 9 (7.0) 5 (11.6) 33 (8.5) Medium
20 Famotidine A02BA03 1 (0.7) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.2) Low
21 Flurbiprofen R02AX01 1 (0.7) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.2) Low
22 Glimepiride A10BB12 3 (2.0) 2 (3.2) 4 (3.1) 0 (0.0) 9 (2.3) Low
23 Glibenclamide A10BB01 7 (5.3) 0 (0.0) 0 (0.0) 0 (0.0) 7 (1.8) Low
24 Hydrocortisone D07AA02 9 (6.0) 4 (6.3) 5 (3.9) 4 (9.3) 22 (5.7) Low
25 Insulin A10AB02 20 (13.3) 13 (20.6) 23 (17.8) 11 (25.6) 67 (17.4) High
26 Ibuprofen M01AE01 4 (2.7) 0 (0.0) 0 (0.0) 0 (0.0) 4 (1.0) Low
27 Ketorolac M01AB15 1 (0.7) 2 (3.2) 0 (0.0) 0 (0.0) 3 (0.7) Low
28 Methylprednisolone D07AC14 2 (1.3) 1 (1.6) 0 (0.0) 0 (0.0) 3 (0.7) Low
29 Metoclopramide A03FA01 5 (3.3) 2 (3.2) 0 (0.0) 0 (0.0) 7 (1.8) Low
30 Meloxicam M01AC06 0 (0.0) 1 (1.6) 0 (0.0) 0 (0.0) 1 (0.2) Low
31 Nifedipine C08CA05 7 (5.3) 1 (1.6) 0 (0.0) 0 (0.0) 8 (2.0) Low
32 Naproxen M02AA12 3 (2.0) 3 (4.8) 0 (0.0) 0 (0.0) 6 (1.5) Low
33 Omeprazole A02BC01 30 (20.0) 18 (28.6) 28 (21.7) 15 (34.9) 91 (23.6) High
34 Orphenadrine N04AB02 9 (6.0) 6 (9.5) 0 (0.0) 7 (16.3) 16 (4.1) Low
35 Piroxicam M01AC01 4 (2.7) 4 (6.3) 0 (0.0) 2 (4.7) 10 (2.5) Low
36 Promethazine R06AD02 1 (0.7) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.2) Low
37 Prednisolone H02AB06 5 (3.3) 4 (6.3) 6 (4.7) 3 (7.0) 18 (4.6) Low
38 Paroxetine N06AB05 3 (2.0) 1 (1.6) 0 (0.0) 0 (0.0) 4 (1.0) Low
39 Pantoprazole A02BC02 1 (0.7) 2 (3.2) 0 (0.0) 0 (0.0) 3 (0.7) Low
40 Ranitidine A02BA02 5 (3.3) 7 (11.1) 5 (3.9) 2 (4.7) 19 (4.9) Low
41 Rabeprazole A02BC04 4 (2.7) 2 (3.2) 0 (0.0) 0 (0.0) 6 (1.5) Low
42 Resperidone N06AX08 1 (0.7) 1 (1.6) 0 (0.0) 0 (0.0) 2 (0.5) Low
43 Tramadol N02AX02 6 (4.0) 2 (3.2) 6 (4.7) 4 (9.3) 18 (4.6) Low
44 Theophylline R03DA04 5 (3.3) 2 (3.2) 3 (2.3) 0 (0.0) 10 (2.5) Low